AisenbergA. C.: Studies on delayed hypersensitivity in Hodgkin's disease.J. Clin. Invest., 41: 1964–1970, 1962.
2.
AisenbergA. C.: Quantitative estimation of the reactivity of normal and Hodgkin's disease lymphocytes with thymidine-2-14C.Nature, 205: 1233–1234, 1965.
3.
AisenbergA. C., LeskowitzS.: Antibody formation in Hodgkin's disease.New Eng. J. Med., 268: 1269–1272, 1963.
4.
BarrM., FairleyG. H.: Circulating antibodies in recticuloses.Lancet, 1: 1305–1310, 1961.
5.
GellerW.: A study of antibody formation in patients with malignant lymphomas.J. Lab. Clin. Med., 42: 232–237, 1953.
6.
HanT., SokalJ. E.: Lymphocyte response to phytohemagglutinin in Hodgkin's disease.Amer. J. Med., 48: 728–734, 1970.
7.
HershE. M., OppenheimJ. J.: Impaired in vitro lymphocyte transformation in Hodgkin's disease.New Eng. J. Med., 273: 1006–1012, 1965.
8.
HoffmannG. T., RottinoA.: Studies of immunologic reactions of patients with Hodgkin's disease. Antibody reaction to typhoid immunization.Arch. Intern. Med, 86: 872–876, 1950.
9.
KellyW. D., GoodR. A., VarcoR. L.: Anergy and skin homograft survival in Hodgkin's disease.Surg. Gynec. Obstet., 107: 565–570, 1958.
10.
LambD., PilneyF., KellyW. D., GoodR. A.: A comparative study of the incidence of anergy in patients with carcinoma, leukemia, Hodgkin's disease and other lymphomas.J. Immunol, 89: 555–558, 1962.
SchierW. W., RothA., OstroffG., ShriftM. H.: Hodgkin's disease and immunity.Amer. J. Med, 20: 94–99, 1956.
13.
SokalJ. E.: Discussion on: Manifestations of immunologic unresponsiveness in Hodgkin's disease.Cancer Res, 26: 1161–1164, 1966.
14.
SokalJ. E., AungstC. W.: Response to BCG vaccination and survival in advanced Hodgkin's disease.Cancer, 24: 128–134, 1969.
15.
SokalJ. E., FiratD.: Varicella-zoster infection in Hodgkin's disease. Clinical and epidemiological aspects.Amer. J. Med, 39: 452–463, 1965.
16.
SokalJ. E., PrimikiriosN.: The delayed skin test response in Hodgkin's disease and lymphosarcoma. Effect of disease activity.Cancer, 14: 597–607, 1961.
